Combined Effect Of Focused- Low- Level Shock Wave Therapy And Low- Level Laser Photobiomodulation Therapy Protocol Improve The Rabbit Carotid Artery Endothelial Dysfunction

2019 ◽  
Vol 287 ◽  
pp. e263
Author(s):  
H. Mehrad ◽  
A.A. Habibzadeh ◽  
M.A. Habibzadeh
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Esma Bilge Göl ◽  
Nilüfer Özkan ◽  
Cihan Bereket ◽  
Mehmet Emin Önger

2019 ◽  
Vol 13 (Supl 1) ◽  
pp. 101S
Author(s):  
Janice De Souza Guimarães ◽  
Fabio Luciano Arcanjo de Jesus ◽  
Gustavo Leporace De Oliveira Lomelino Soares ◽  
Leonardo Fossati Metsavaht ◽  
Túlio Eduardo Marçal Vieira ◽  
...  

Introduction: Plantar fasciitis (PF) is one of the common reasons for foot pain and is associated with substantial health and economic burden. PF often responds to a wide range of therapies that are predominantly conservative. We performed a meta-analysis to investigate the effects of low-level laser therapy on pain and disability in patients with PF. Methods: Studies were comprehensively searched in Pubmed MEDLINE, the PEDro database, the Scientific Electronic Library Online, and the Cochrane Central Register of Controlled Trials, from the earliest date available to January 2019. Randomized controlled trials that evaluated the effects of low-level laser therapy versus control or another intervention for patients with PF were included. Mean differences (MD) and 95% confidence intervals (CIs) were calculated, and heterogeneity was assessed using the I2 test. Calculations were performed using a random effects model, with two comparisons: low-level laser therapy compared with the control (no intervention); low-level laser therapy compared with extracorporeal shock wave therapy. Results: Eight trials met the study criteria, including 473 PF patients. The main outcomes included changes from baseline in the Visual Analogue Scale Score (pain) and Foot Function Index (disability). Low-level laser therapy resulted in improvement in pain MD (-2.27 95% CI: -2.72 to -1.82 N=184) compared with the control. No significant difference in disability MD (-1.81 95% CI: -7.4 to 3.8 N=110) was found in participants in the low-level laser therapy group compared with the control group. Compared with extracorporeal shock wave therapy, low-level laser therapy did not achieve a significant reduction in pain intensity MD (0.45 95% CI: -2.4 to 3.3 N=141). In addition, no serious adverse events were reported.  Conclusion: Low-level laser therapy may improve pain and should be considered as a component of care for PF patients. However, this superiority disappeared when it was compared to extracorporeal shock wave therapy.  


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Sergey Moskvin ◽  
Evgeniy Askhadulin ◽  
Andrey Kochetkov

Objectives. The aim of the article is to justify the application of low-level laser therapy (LLLT) to prevent the development of endothelial dysfunction in COVID-19 patients. The results of treating and rehabilitating patients with COVID-19 and prevention of the disease using low-level laser therapy (LLLT) are evaluated. Methods. A literature review is conducted on mechanisms of vascular homeostasis regulation, biomodulating effect of laser light, and LLLT methods for preventing endothelial dysfunction. A total of 106 patients were treated in two COVID-19 healthcare centers in Russia. 22 patients with SARS (+) pneumonia at the stage of resolving the pathological lesion were admitted to rehabilitation using pulsed IR laser. 14 patients with acute forms of COVID-19 were treated using LASMIK device: wavelength 904 nm, pulsed mode, externally and ILBI-525 (intravenous laser blood illumination) + LUVBI (ultraviolet laser blood illumination). 70 persons underwent preventive courses of noninvasive LLLT. Results. It was shown that LLLT is effective in preventing the development of endothelial dysfunction. Clinical experience demonstrated good tolerability of the treatment, improvement in sputum discharge, and an improvement in overall health. The severity of general hypoxia decreased by the 5th procedure. The procedures for prevention of the disease were well tolerated; there were no cases of COVID-19. Conclusion. Low-level laser therapy is a justified treatment method that promotes lung tissue regeneration and mitigates the consequences of the disease. The obtained results confirm that LLLT can be used for the effective prevention and treatment of COVID-19 patients.


Sign in / Sign up

Export Citation Format

Share Document